Difference between revisions of "Zhou P, et al. Mol. Cancer (2017) cited as Ref 457 in DOI: 10.1038/s41392-020-0110-5 (Q9720)"
Jump to navigation
Jump to search
(Created claim: Volume (P103): 16, #quickstatements; #temporary_batch_1590009084631) |
(Created claim: title (P93): The epithelial to mesenchymal transition (EMT) and cancer stem cells: implication for treatment resistance in pancreatic cancer, #quickstatements; #temporary_batch_1590010982689) |
||
| Property / title | |||
| + | The epithelial to mesenchymal transition (EMT) and cancer stem cells: implication for treatment resistance in pancreatic cancer (English) | ||
| Property / title: The epithelial to mesenchymal transition (EMT) and cancer stem cells: implication for treatment resistance in pancreatic cancer (English) / rank | |||
| + | Normal rank | ||
Revision as of 22:02, 20 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Zhou P, et al. Mol. Cancer (2017) cited as Ref 457 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Zhou P
0 references
2017
0 references
Mol. Cancer
0 references
16
0 references
The epithelial to mesenchymal transition (EMT) and cancer stem cells: implication for treatment resistance in pancreatic cancer (English)
0 references
